Skip to Content

VIO9111 9111 (Viokace 39,150 USP units amylase; 10,440 USP units lipase; 39,150 USP units protease)

Generic Name: pancrelipase

Pill with imprint VIO9111 9111 is Tan, Round and has been identified as Viokace 39,150 USP units amylase; 10,440 USP units lipase; 39,150 USP units protease. It is supplied by Allergan, Inc..

Viokace is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Viokace 39,150 USP units amylase; 10,440 USP units lipase; 39,150 USP units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for VIO9111 9111

Viokace 39,150 USP units amylase; 10,440 USP units lipase; 39,150 USP units protease VIO9111 9111

Viokace

Generic Name
pancrelipase
Imprint
VIO9111 9111
Strength
39,150 USP units amylase; 10,440 USP units lipase; 39,150 USP units protease
Color
Tan
Size
13.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Digestive enzymes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Allergan, Inc.
National Drug Code (NDC)
58914-0112
Inactive Ingredients
lactose monohydrate, croscarmellose sodium, stearic acid, microcrystalline cellulose, silicon dioxide, magnesium silicate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.